Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: REGENERON PHARMACEUTICALS INC, REGENERON PHARMACEUTICALS INC., REGENERON PHARMACEUTICALS, INC, REGENERON PHARMACEUTICALS, INC., REGENERON PHARMACEUTICALS INC., REGENERON PHARMACEUTICALS, INC, REGENERON PHARMACEUTICALS, INC.
Client-Reported Lobbying Expenses
$14.3M
195 filings
Firm Income Reported for This Client
$8.5M
Not substituted for client expenses
Contract Awards
$6.86B
16 awards
SEC Insider
$22.74B
8,659 transactions
Summary
REGENERON PHARMACEUTICALS, INC. (REGN) is an organization, based in NY. Its political footprint includes $14.3 million in client-reported lobbying expenses, $8.5 million in lobbying-firm income reported for this client, $6.86 billion in government contracts. Lobbying activity focuses on Health Issues, Medicare/Medicaid, Budget/Appropriations, Copyright/Patent/Trademark. Their largest government contract source is Department of Defense at $5.57 billion. Political activity spans from 2008 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↑ 34% YoY
2025: $2.2M (complete years)
Insider Trading
38 insiders
Political Money Flow
Government agencies → REGENERON PHARMACEUTIC... (contracts) → political recipients & lobbying. Hover for details.
SEC filings: SEC EDGAR
Activity data: Senate LDA · USAspending.gov · SEC EDGAR